Pentoxifylline in treatment of sepsis of premature infants

JK Practitioner

Volumn 13, Issue 4, 2006, Pages 204-207

  Ali, Wajid ^a   Ahmed, Parvez ^a   Bhat, Mushtaq A ^a   Mushtaq, Sheikh ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Pentoxifylline; Premature infants; Sepsis; Shock

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; DOBUTAMINE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; DRUG SAFETY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; IRRITABILITY; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN SEPSIS; OBSTRUCTIVE JAUNDICE; PREMATURITY; SHOCK; SIDE EFFECT; SURVIVAL; THROMBOCYTOPENIA; TREATMENT DURATION;

EID: 34249023380     PISSN: 09718834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor alpha concentration in premature infants with sepsis. Eur J Pediatr. 1996 May;155(5); 404-9.
2. Mandi Y, Farkas G, Ocsovzky I; Effects of Pentoxifylline and pentaglobin on TNF and IL-6 production in septic patients. Acta Microbiol Immunol Hung 1995;42:301-8
3. Zeni F, Pain P, Vindimian M etal. Effects of Pentoxifylline on circulating cytokine concentrations and haemodynamics in patients with septic shock: Results from a double blind randomized placebo controlled study. Crit Care Med 1996;24: 207-14
4. Bienvenu J, Doche C, Gutowski Mc, etal: production of proinflammatory cytokines involved in TH1/TH2 balance modulated by Pentoxifylline. J Cardiovas pharm 1995;25:S80-S84
5. Lundblad R, Ekstrom P, Giercksky KE. Pentoxifylline improves survival and reduces TNF, IL-6, and endothelin-1 in fulminant intra abdominal sepsis in rats. Shock 1995;3:210-15
6. Steeb GD, Wilson MA, Garrison RN. Pentoxifylline preserves small intestinal micro vascular blood flow during becteremia. Surgery 1992;112:756-63.
7. Bacher A, Mayer N, Klimscha W etal; effects of Pentoxifylline on haemodynamic and oxygenation in septic and non septic patients .Crit Care Med 1997;25:795-800.
8. Krysztopik RJ, Bentley FR, Wilson MA: free radical scavenging by lazaroids improves renal blood flow during sepsis. Surgery 1996;20:657-62
9. Yang S, Zhov M,Koo DJ: Pentoxifylline prevents transition from hyper dynamic to hypo dynamic response during sepsis. Am J Physiol 1999;277:H1036-H1044.
10. Lauterbach R. Pentoxifylline treatment of persistent pulmonary hypertension of newborn. Eur J Pediatr 1993, 1525: 460,
11. Lauterbach R, Pawlik D. Pentoxifylline treatment of sepsis of premature infants. Preliminary clinical observations. Eur J Pediatr 1994,153: 672-674
12. Wang P, Wood TJ, Baz F, Pentoxifylline maintains vascular endothelial cell function during hyper dynamic sepsis. Surgery 1996;130:367-73
13. Boldt J, Muller M; Influence of long term continuous intravenous administration of Pentoxifylline on endothelial related coagulation in critically ill patients. Crit Care Med 1996;24:940-46.
14. Schroer R. anti thrombotic potential of Pentoxifylline, a haemorrheologically active drug. Angiology 1985;36:387-98.
15. Matzky R,Darius H. The release of prostacycline (PGI2) by Pentoxifylline from human vascular tissue. Arzneimitte eforschung 1982;32:1315-18.
16. Zheng H, Crowley J. Attenuation of LPS induced neutrophil thromboxane B2 release and chemiluminescence. J Cell Physiol 1991;146: 264-69.
17. Boldt J, Miller. Does long term continuous intravenous administration of Pentoxifylline affect platelet function in critically ill patients. Intensive Care Med 1996;22:644-50.
18. Betticher C, Keller H: Effect of endotoxin and TNF on erythrocyte and leukocyte deformability. Br. J. Haematol.1993;83:130-37.
19. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994;30:603-21.
20. Vanleonen D, Poll T Vander, Levi M: Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 1993, 151:2318-2325.
21. Jun XM, Hsueh W: Bowel necrosis induced by TNF in rats is mediated by platelet activating factor. J Clin Invest, 1988,81:1328-1332.
22. Lauterbach R, Pawlik D: Prevention and treatment of chronic lung disease. Acta Paediatr Suppl. Feb 2004; 93 (444): 20-2.